Individuals Stopping Weight-Loss Medications Put On Weight at a Quadrupled Rate Than Those on Conventional Diets
New research indicates that patients who discontinue popular GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight far faster than those who stop conventional diet and exercise programs.
Research printed in a prominent health publication points out that while obese people frequently drop about a fifth of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing such drugs need to be informed of the danger of rapid rebound weight gain when the therapy ends," warns lead investigator Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting mass within about one and a half years.
Comparing Approaches
The analysis, which reviewed dozens of trials involving thousands of participants, compared the effects of GLP-1 agonists with other pills.
Researchers emphasize that people who shed pounds through dieting usually have a more gradual creep back—approximately 100 grams monthly—post-intervention.
The Reason for the Fast Regain
Doctors suggest the way of the injections is key to understanding the accelerated weight return.
The injections mimic a natural hormone called GLP-1, which controls feelings of fullness.
"Long-term administration of the hormone levels far above than the body's typical production might result in the body to generate a reduced amount of its own natural hormone, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication leads to hunger is no longer kept in check, making overeating a significant risk."
A Lifelong Condition?
The NHS recommend the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.
Many experts argue that, given the high risk of weight regain, the treatment is often ongoing.
This opinion is reinforced by drug manufacturers, who say that the results "underscore the chronic nature of excess weight," similar to managing conditions like diabetes.
Patient Testimonies
People who have stopped the jabs describe a sudden return of hunger.
"It was like a switch that goes on and you become extremely hungry," said an individual.
This difficulty is exacerbated if users have not established permanent dietary or behavioural changes during therapy.
Widespread Interest
Recent estimates indicate that millions of people in the UK have tried these injections in the past year, with desire being substantial.
- Adoption is more common among females than men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the medications through private healthcare rather than the NHS.
In conclusion, clinicians caution that while these medications are potent tools for weight loss, they are not a standalone fix and maintained weight loss relies on ongoing behavioural management.